Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study.
about
An overview of sarcopenia: facts and numbers on prevalence and clinical impactSarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons--a narrative reviewProtein: A nutrient in focusVitamin D signaling in myogenesis: potential for treatment of sarcopeniaElderly Mexicans have less muscle and greater total and truncal fat compared to African-Americans and Caucasians with the same BMI.Lean mass, muscle strength, and physical function in a diverse population of men: a population-based cross-sectional study.Sex impacts the relation between body composition and physical function in older adultsUncomplicated resistance training and health-related outcomes: evidence for a public health mandateA systematic review of the evidence that brain structure is related to muscle structure and their relationship to brain and muscle function in humans over the lifecourse.Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA).Resistance training predicts 6-yr body composition change in postmenopausal women.The impact of sarcopenia on a physical activity intervention: the Lifestyle Interventions and Independence for Elders Pilot Study (LIFE-P).Functional consequences of sarcopenia and dynapenia in the elderly.A multi-cohort study of polymorphisms in the GH/IGF axis and physical capability: the HALCyon programme.Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility.Osteosarcopenic obesity: the role of bone, muscle, and fat on healthHighlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.Exercise attenuates the major hallmarks of aging.Stair descending exercise increases muscle strength in elderly males with chronic heart failure.The physical capability of community-based men and women from a British cohort: the European Prospective Investigation into Cancer (EPIC)-Norfolk study.Sarcopenia: clinical evaluation, biological markers and other evaluation tools.Clinical Implications for Muscle Strength Differences in Women of Different Age and Racial Groups: The WIN StudyIdentification of serum biomarkers for aging and anabolic responseBed rest promotes reductions in walking speed, functional parameters, and aerobic fitness in older, healthy adults.Clustering of strength, physical function, muscle, and adiposity characteristics and risk of disability in older adultsSkeletal muscle protein metabolism in the elderly: Interventions to counteract the 'anabolic resistance' of ageing.Dynapenia and aging: an update.Protecting muscle mass and function in older adults during bed restIncreases in muscle strength and balance using a resistance training program administered via a telecommunications system in older adults.Muscle Quality and Muscle Fat Infiltration in Relation to Incident Mobility Disability and Gait Speed Decline: the Age, Gene/Environment Susceptibility-Reykjavik StudySarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopeniaInteraction between bone and muscle in older persons with mobility limitationsDevelopment of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL.Malnutrition-sarcopenia syndrome: is this the future of nutrition screening and assessment for older adults?From muscle wasting to sarcopenia and myopenia: update 2012Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study.Effects of whole-body vibration on proxies of muscle strength in old adults: a systematic review and meta-analysis on the role of physical capacity level.Sarcopenia: age-related skeletal muscle changes from determinants to physical disability.Evidence-based criteria for sarcopenia with clinically important weaknessSarcopenia and obesity: gender-different relationship with functional limitation in older persons.
P2860
Q24633887-8195E070-22A5-4474-89A8-FD75D8AFB888Q26783216-00A679D9-D0DF-45D2-BDA8-BB821843B1C2Q26801356-852302E7-EAAD-487F-B2E1-E060B8A0CC27Q26849642-706BEC29-CA43-46DB-A65D-0D07F4E8054FQ33643704-BFF6D609-8CE1-4539-9844-6A2EDAF4E621Q33667652-BF916981-CC2D-4E44-9EAE-49828D5784A0Q33748733-C24B7D8D-ECB2-40AD-9C14-1FC872BEFCDEQ33862152-70707B0E-F976-4D0F-B092-B19C441B33E0Q33929253-8E7C6830-E516-405E-B900-5AC304AEAB68Q33932870-33A34845-4D3C-49FE-BFD8-CBCBE8DE6F46Q33940627-3ADB65BA-D621-4FFC-B297-29B220518C86Q33950862-7A674EE6-EC02-427B-AC45-05F833C84663Q33954694-731C8D6B-9A28-4C16-A7E0-24045A674B7AQ34130759-FB087F62-EF3A-417E-BF97-590863E709A7Q34156968-20D5F6E9-F043-4C96-B099-20003CD9B01FQ34156977-D8FBEB5E-A615-4FF0-B4E1-1D28CDD7A63AQ34334313-09A6D905-7E3B-433A-9B42-4068D32D4656Q34449998-9D123B52-82FE-4CDA-842F-81EF91432568Q34627820-5BF6FEB9-44D1-40D7-88B0-CF4B0982272FQ34983103-E9DEAA9F-2EDB-4F81-B98B-B904B1DBD5D6Q35034119-DDC5C4CF-C027-41B8-9507-030552270F6AQ35034518-987AB7E5-8F03-428D-85B6-CC71DEB6B8A3Q35102878-AA2F8F0B-24E7-4AD6-AD86-51AC146F11AEQ35127279-118FC001-6167-4733-AE7C-244B1FAB98FEQ35382131-62793624-AB85-468A-A26A-4DDB1B965F39Q35447810-E7667B15-1547-45F4-906F-5B368FC26F5CQ35678530-09749CA4-3191-4562-9E20-2B2617059B5EQ35746945-4338A340-A2DC-4E93-AD98-7A19FB270C97Q35832066-4B07B2AA-3A8F-44D4-BA9C-79A5B208448CQ35862958-44DD07B0-9A3A-4854-8742-AA9A06BD6D16Q36039024-4B58991E-8CC9-4334-91C6-A63DE44940EEQ36100758-05B68135-0CAB-4DA0-B163-C20AD4DE5A6AQ36208526-51D267F9-8F41-4AA5-84BD-A25ADFFF3199Q36253594-B48A5AD7-4E7B-4E90-BB01-D212FA96AB45Q36421054-A3FA9DAF-B033-44A8-9330-94B7A67C546CQ36539322-036BE272-6734-424B-82E2-64EC03F613BFQ36565297-A0E19EF0-D498-45E2-8516-DBD1CCA55776Q36682349-FBE0F513-6E55-41E1-A953-DAA13C1AFA8FQ36950810-67A8397A-4140-4B71-8429-F654D0C2EA50Q37001643-A25052D0-E887-45EB-84D6-18E811E16F0B
P2860
Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Influence of sarcopenia on the ...... e Cardiovascular Health Study.
@en
Influence of sarcopenia on the ...... e Cardiovascular Health Study.
@nl
type
label
Influence of sarcopenia on the ...... e Cardiovascular Health Study.
@en
Influence of sarcopenia on the ...... e Cardiovascular Health Study.
@nl
prefLabel
Influence of sarcopenia on the ...... e Cardiovascular Health Study.
@en
Influence of sarcopenia on the ...... e Cardiovascular Health Study.
@nl
P1476
Influence of sarcopenia on the ...... e Cardiovascular Health Study.
@en
P356
10.1111/J.1532-5415.2005.00540.X
P407
P50
P577
2006-01-01T00:00:00Z